47 related articles for article (PubMed ID: 11466563)
1. Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Mudu MC; Mulas C; Lusso MR; Gramignano G; Piras MB
J Mol Med (Berl); 2001 Jul; 79(7):406-14. PubMed ID: 11466563
[TBL] [Abstract][Full Text] [Related]
2. L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis.
Wu C; Zhu M; Lu Z; Zhang Y; Li L; Li N; Yin L; Wang H; Song W; Xu H
Nutr Metab (Lond); 2021 Nov; 18(1):98. PubMed ID: 34724970
[TBL] [Abstract][Full Text] [Related]
3. Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease.
Maccio A; Sanna E; Neri M; Oppi S; Madeddu C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809200
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and Skeletal Muscle Wasting During Cachexia.
Webster JM; Kempen LJAP; Hardy RS; Langen RCJ
Front Physiol; 2020; 11():597675. PubMed ID: 33329046
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes.
Amgarth-Duff I; Hosie A; Caplan G; Agar M
BMC Psychiatry; 2020 Apr; 20(1):182. PubMed ID: 32321448
[TBL] [Abstract][Full Text] [Related]
6. Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia.
Levolger S; van den Engel S; Ambagtsheer G; IJzermans JNM; de Bruin RWF
Aging (Albany NY); 2018 Dec; 10(12):4213-4223. PubMed ID: 30591621
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach.
Madeddu C; Gramignano G; Astara G; Demontis R; Sanna E; Atzeni V; Macciò A
Front Physiol; 2018; 9():1294. PubMed ID: 30294279
[TBL] [Abstract][Full Text] [Related]
8. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis.
Lippitz BE; Harris RA
Oncoimmunology; 2016 May; 5(5):e1093722. PubMed ID: 27467926
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer.
Fujiwara Y; Kobayashi T; Chayahara N; Imamura Y; Toyoda M; Kiyota N; Mukohara T; Nishiumi S; Azuma T; Yoshida M; Minami H
PLoS One; 2014; 9(11):e113259. PubMed ID: 25411961
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
Choi YK; Jung KY; Woo SM; Yun YJ; Jun CY; Park JH; Shin YC; Cho SG; Ko SG
Mediators Inflamm; 2014; 2014():736563. PubMed ID: 24963216
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.
Macciò A; Madeddu C
J Mol Med (Berl); 2013 Dec; 91(12):1355-68. PubMed ID: 24057813
[TBL] [Abstract][Full Text] [Related]
12. Adipokines and systemic inflammation in weight-losing lung cancer patients.
Gulen ST; Karadag F; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
Lung; 2012 Jun; 190(3):327-32. PubMed ID: 22246553
[TBL] [Abstract][Full Text] [Related]
13. l-carnitine and cancer cachexia: Clinical and experimental aspects.
Silvério R; Laviano A; Rossi Fanelli F; Seelaender M
J Cachexia Sarcopenia Muscle; 2011 Mar; 2(1):37-44. PubMed ID: 21475677
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies.
Burckart K; Beca S; Urban RJ; Sheffield-Moore M
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):410-6. PubMed ID: 20473155
[TBL] [Abstract][Full Text] [Related]
15. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Massa D; Astara G; Chessa P; Mantovani G
J Mol Med (Berl); 2010 Jul; 88(7):677-86. PubMed ID: 20339829
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients.
Macciò A; Madeddu C; Massa D; Astara G; Farci D; Melis GB; Mantovani G
J Cell Mol Med; 2009 Sep; 13(9B):3951-9. PubMed ID: 18624749
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children.
Aygun AD; Gungor S; Ustundag B; Gurgoze MK; Sen Y
Mediators Inflamm; 2005 Aug; 2005(3):180-3. PubMed ID: 16106106
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Massa E; Mocci M; Serpe R
J Mol Med (Berl); 2003 Oct; 81(10):664-73. PubMed ID: 12928788
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
